< F2D398B5A8CA495F1328CB4328D5A2E6A7464>
|
|
|
- かずただ たつざわ
- 7 years ago
- Views:
Transcription
1 2007 Time required for developing protective immunity against coldwater disease in cultured Ayu Plecoglossus altivelis altivelis after vaccination Hideo HARA* Plecoglossus altivelis altivelis Flavobacterium psychrophilum MC MC MC g PH L - ml/cgygg glphml rpm mlml/cgy ml FKB CFU/mL FKBrpm / FKB FKB ISA-A FA L FKB Montanidae IMS IMS IMSFKB MCMC DKF-% mlimsfkbml gml gmlml ml MC *
2 MC kgmcg MC MC PHmL/CGY ml rpmml ml/cgyml CFU/mL/CGY CFU/mL CFU/mL ml L mmmmmm L/ Fisher Relative percent survival :RPS=- /Cory and Amend g CFU/mL CFU/mL CFU/mL CFU/mL CFU/mL RPS P RPS- RPS - P RPS-- P RPS
3
4 アユ冷水病ワクチンの効果発現時期 2 1 無処理対照区 注射ワクチン区 経口ワクチン区 ３日後攻撃 攻撃菌数 CFU/ｍL 5 ３日後攻撃 攻撃菌数 CFU/ｍL) ７日後攻撃 攻撃菌数 CFU/ｍL ７日後攻撃 攻撃菌数 CFU/ｍL 日後攻撃 攻撃菌数 CFU/ｍL 日後攻撃 攻撃菌数 CFU/ｍL 図１ 試験１における攻撃試験のの推移
5 RPS(%) ワクチン 投 与 完 了 から 攻 撃 開 始 までの 日 数 RPS RPS(%) ワクチン 投 与 完 了 から 攻 撃 開 始 までの 日 数 RPS
6 アユ冷水病ワクチンの効果発現時期 2 1 無処理対照区 注射ワクチン区 経口ワクチン区 ３日後攻撃 攻撃菌数 CFU/ｍL ３日後攻撃 攻撃菌数 CFU/ｍL 2 1 ７日後攻撃 攻撃菌数 CFU/ｍL 14日後攻撃 攻撃菌数 CFU/ｍL 日後攻撃 攻撃菌数 CFU/ｍL 図３ 試験２における攻撃試験のの推移
7 gg MC g g g RPS RPS MC RPS % MC MC RPS g Oncorhynchus mykiss g MC gg g MC g MC Wakabayashi H Toyama T and Iida T A study on serotyping of Cytophaga psychrophila isolated from fishes in Japan Fish Pathol Rahaman M H Ototake M Iida Y Yokomizo Y and Nakanishi T Efficacy of oil-adjuvanted vaccine for coldwater disease in ayu Plecoglossus altivelis Fish Pathol Rahaman M H Ototake M and Nakanishi T Water-soluble adjuvants enhance the protective effect of Flavobacterium psychrophilum vaccines in ayu Plecoglossus
8 altivelis Fish Pathol - CORY T R and AMEND D F Immunization of sockeye salmononcorhynchus nerka against vibriosis using the hyperosmotic infiltration techniqueaquaculture : : -
untitled
237 238 G 8-1 239 240 G - 241 242 G - 243 244 G 8-2 245 246 G - 247 248 G 8-3 900 600 249 250 G 8-3 251 252 G 8-5 253 254 G 8-5 255 700 700mm800mm850mm 256 G - 257 258 G 8-7 259 35 7.5 100 100 8 260 G
2004 3 16 3 ( 2003 6 ) Lethenteron reissneri Anguilla japonica Hypomesus nipponensis Plecoglossus alteviles altivelis Salangichthys microdon Salvelimus leucomaenis leucomaenis Salvelimus leucomaenis pluvius
untitled
50 5 2010 8 5 500 9 1999 05 08 09 1 2009 (LAC: ) ( 1999 10 2 3 2010 Vaccine 28(2010) 3134-3142) 2009 5 6 7 8 9 Q & A Time after Class 80 90 10 11 1 13 12 13 2009 15 16 17 18 19 2009 10 20 21 22 23 24 25
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
L- 19 L L- L-
0131001 15 1 31 49 35 145 14 5 19 4 23 15 3 10 7 15 634 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 L- 19 L- 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
Journal of Fisheries Technology, 3 2, , , , 2011 The Development of Artificial Spawning Grounds for Ayu, Plecoglossus altivelis
Journal of Fisheries Technology, 3 2, 137 145, 2011 3 2, 137 145, 2011 The Development of Artificial Spawning Grounds for Ayu, Plecoglossus altivelis altivelis Masayoshi KONDO, Koichi IZUMIKAWA, Katashi
Table 1.Concentration of gatifloxacin (Middle-ear) Table 2.Concentration of gatifloxacin (Paranasal sinuses) Table 3.Concentration of gatifloxacin (Tonsil) Table 4.No.of patients studied Table 5.Background
MC-440 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
< F2D82CD82B682DF82C E E6A7464>
I 50 ml 1.5 ml SS PCR TaKaRa EX Taq Hot Start Version PCR PCR 27 50 ml SS 1,500 rpm400 g1 SS 50 ml 5 ml 3 ml 28 SS 1 25 24 1,000 rpm180 g3 29 1 ml 1.5 ml 5,000rpm2,430 g5 SS D.W. 100 µl 100 5 10,000 rpm5
橡14yoshi
8~9 GSI 5cm 35.8g16.7~58.2g 63.0g20.7~124.2g 61.4g20.4 ~102.2g 17 GSI 1.1 0~5.2 4.0 0~17.7 1.9 0~9.6 1.2 0~4.5 0.60~2.6 0.50~2.2 67 66 76 60 3 9.5~27.5 8.9g1.7~9.6 3.6g1.3~6.3 5.3g 2.0~9.2 4.6g 2.1~8.1
23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213
offer vol.24OUTPUT
Toyama Design Magazine http://www.toyamadesign.jp/ vol.24 Toyama Design Magazine 2 3 5 12 13 vol.24 CONTENTS 15 17 TOPICS pick up 19 21 22 COVER P R O F I L E http://www.toyamadesign.jp/ vol.24 kato hideo
1 2 4 6 8 10 12 20 22 26 28 30 34 36 42 44 46 48 50 54 56 58 60 62 64 2 3 4 5 6 12,403 3,253 26.2% 3,539 28.5% 1,934 15.6% 2,283 18.4% 487 3.9% 907 7.3% 7 OSAKA 810,000 1102 644 54 135 976 32,000 Amazon.co.jp
2 / 7
1 / 7 1.30 1.301.00m 2.00 2.001.00m 1.70 1.701.00m 2.4 2.41.0m 2.0 2.01.0m 1.08 1.20.9m 1.08 1.20.9m 2.5 2.51.0m 2.5 2.51.0m 0.9 1.00.9m 1.44 1.60.9m 2 / 7 ml ml 3 / 7 4 / 7 ) 5 / 7 6 / 7 0798-56-1710
2 (1) (2) SCI 2 SCI 2 24 2 12 2
2004 (1) (2) (2) (3) (1) 1 (2) (3) 2 (1) (2) SCI 2 SCI 2 24 2 12 2 100% / 16 2002 2003 http://lin.lin.go.jp/alic/month/dome/1997/nov/chousa.htm (05 612 1315 1618 1922 2329 3039 4049 5059 60 ) =10 b g 1
3 4
2 3 4 5 6 Contents 117 9 30 10 00 10 30 12 00 13 30 15 30 1700 15 00 9 30 10 00 Contents 118 11 30 13 00 14 30 15 00 1630 7 22 36 8 7 Report MC 2000 Report MC 2000 10 9 12 11 14 13 16 15 18 17 20 19 22
Ⅱ6.3界面活性剤
6.3 6.3.1 6.3.1 6.3.1.1 (1) (2) a) JIS K 0557 A3 b) JIS K 8891 c) (5g/L) d) (10g/L)JIS K 8576 1g 100mL e) (7+993)JIS K 8951 f) JIS K 8322 g) 0.1g 100mL 30mL 1L 500mL6.8mL 50g 1L h) 1L 500mL6.8mL 50g 1L
-51-
-50- -51- 11 3 28 8 1 24 7 2 36 10 1-52- -53- 1 2-54- 6 1 2 3 4 5 6 6 1 19 5 200 300ml 20 6 400ml -55- -56- 10-57- 4 2 20-58- 2,500-59- -60- -61- 2-62- 6 3-63- 9 68 1 6-64- 3-65- 4-66- 5 6-67- -68- 1 1
2006年3月8日
18 21 1990 2004 2 2005 14 15 2004 1990 2005 2003 300 7 2 1 2005 1972 100 40 6 1972 2004 197 6,500 2004 21 59 100 65 2007 5 2005 30 1.8 535.89 348.33 187.56 2006 2006 5 1 30 1 30 46 46 1 46 1000kl 4 1 100kl
bc0710_010_015.indd
Case Study.01 Case Study.02 30 Case Study.05 Case Study.03 Case Study.04 Case Study.06 Case Study.07 Case Study.08 Case Study.21 Case Study.22 Case Study.24 Case Study.23 Case Study.25 Case Study.26
Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood
Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood Fig.1 Distribution of the cases with bacterial meningitis by age and pathogens Chiba
「諸雑公文書」整理の中間報告
30 10 3 from to 10 from to ( ) ( ) 20 20 20 20 20 35 8 39 11 41 10 41 9 41 7 43 13 41 11 42 7 42 11 41 7 42 10 4 4 8 4 30 10 ( ) ( ) 17 23 5 11 5 8 8 11 11 13 14 15 16 17 121 767 1,225 2.9 18.7 29.8 3.9
No.10
Unio Internationalis Contra Cancrum International Union Against Cancer UICC UICC 2009.4 1 UICC News Letter No.10 2 2009.4 3 UICC News Letter No.10 4 2009.4 5 UICC News Letter No.10 6 The fight against
t Z
t Z 1 11 1 1 1 1 1 1 1 1 1 1 1 1 UU 1 as a s 1 1 1 1 1 1 G q w e r q q w e r a s 1 1 1 1 1 1 1 a s a gg g q w e r 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
こんにちは由美子です
Prevalence (proportion) 1. 1991 23.8 2. 1960 52 85 2477 310 cross sectional study prevalence Time referent: prevalence 1985 40 45 prevalence 0.5 80 85 43 Time referent 1985 time referent Risk and Cumulative
橡kenkyuhoukoku８.PDF
10-1- -2- 11 21 10 5 12 1 10 0 5 3-3- -4-10 75 3 10 10 75 100 10 75 5 10 (1) (2) -5- (3) -6- (4) 27 11.290 291-7- (5) 1 1-8- 1 (6) 51 (7) -9- (1) (2) -10- (3) -11- (4) -12- -13- (5) (6) (7) (1) (2) -14-
3 JAS JAS JAS 4
1 2 3 JAS JAS JAS 4 5 6 7 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ph 102 106 K 31 32 13 3 15 79 33 34 35 36 37 20 6 H.22.3 http://www.caa.go.jp/foods/pdf/syokuhin19.pdf 38
Microsoft Word - news2010.no17.doc
2010 年 9 月 5 日 10:20 試 合 開 始 ( 於 ) 明 治 神 宮 外 苑 野 場 チーム 1 2 3 4 5 6 7 計 JA 1 1 4 1 0 0 0 7 JB 1 0 2 0 0 0 3 6 2010 年 9 月 5 日 12:15 試 合 開 始 ( 於 ) 明 治 神 宮 外 苑 野 場 1) 2) 2010 年 9 月 5 日 14:10 試 合 開 始 ( 於 )
校正（1）神奈川自然誌28.indd
Noriyuki Nagai and Kazuhisa Saitou: Fish Fauna of Fudo River System, Oiso and Hiratsuka, Kanagawa Prefecture 85 St.No. [] [] 1 H16.9.19 9:25 9:35 26.0 22.7 2 H16.9.19 9:45 10:05 30.5 22.5 3 H16.9.19 10:15
AAS44.indd
2 Nakane, T. (2014). Recognition of the different structural forms of the capsid protein determines the outcome following infection with Porcine Circovirus Type 2 All about SWINE 44, 16-28 2 PCV2 porcine
untitled
- 1 - - 2 - OFF - 3 - 18-4 - - 5 - - 6 - (1) (2) No 1 0099240130 CL-10 2 0099240040 CL-3-7 - - 8 - 50Hz 250 / - 9 - 6. 1 6. 2 R 6. 3 V 6. 4 R - 10 - 6. 5 6. 6 6. 7-11 - 6. 8 500mm 6. 9 4. 6. 10-12 - 6.
Effect of Cooking Water ph on Commercial Sterility in the Production of Cooked Rice Packed under Semi-aseptic Condition Kinya SAKUMAl, Haruhiko KATODA1, Tetsuya FUKAYA2, Toshio JOH3, Akira IT03 and Atsuo
untitled
RYZA IL & FAT CHEMICAL C., LTD. SAKURA EXTRACT Ver.1.4MK Ver. 1.4MK 1) 1300 1929 1 Ver. 1.4MK Sakura 1-caffeoyl---D-glucopyranoside quercetin 3---D-glucopyranoside 1) :, 4, 11-22 (1995). 2 Ver. 1.4MK 3
1911~20 1921~30 1931~40 area M area A area I *p 6 Ostomy Care
6 Ostomy Care 6 * * IMS 4 1,800 350 150 IMS P. 8 P.18 P.26 P.33 P.34 P.35 P.36 P.42 P.44 P.46 P.34 P.43 7 / 8 9 1. 2. 3. 2014 Mio 1-4 * 1 ph 88%* 2 *1 0.5 1 *2 2013 6310 CPBES * 3 PIB EVA SIS CMC *3 10
P000-063.....s.....v..
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2.8% 29.9% 54.1% 6.9% 5.6% 0.7% 2.6% 30.8% 54.0% 6.5% 5.5% 0.6% 33.6% 3.5% 52.9% 5.7% 4.0% 0.3% 2.8% 17.5% 58.7% 11.5% 8.0% 1.5% 30.3% 51.3% 7.9% 9.2% 1.3% 0.0%
untitled
ver. 3.3JT EVENING PRIMROSE EXTRACT 1 - PMS 1 2 1 4 Oenothera laciniata Oenothera striata Oenothera biennis Oenothera erythrosepala - 2 80 60 40 20 0 1. 2 3 PGGPAC 2. 3 4 ESR3.5 10 5 /g 4 3 1 Helicobacter
表紙／木下 平島
IN GOTO Ab alto ad altum IN GOTO Christine Kistler Christine Kistler IN GOTO 1 Christine Kistler Christine Kistler Christine Kistler 2 3 4 7 8 Primary Care MedicineFamily Medicine Family Practice General
エンジョイ北スポーツ
2772083130 83 1 2 3 4 5 6 7 8 2 2 2 3 3 4 4 6 7 8 1211 53 /15,171 /509 /670 /13,992 2 83130 http://www.kita-city-taikyo.or.jp 83130 http://www.kita-city-taikyo.or.jp 3 68 35 45 4 83130 http://www.kita-city-taikyo.or.jp
スライド 1
19 9 9 26 39 38 100 300 30 37 1 2 3 4 5 6 7 2004 Vol.132(12) Web http://www.nsknet.or.jp/katoh/honbun.html http://www.hyo-med.ac.jp/department/ped/qa/rota.html http://kodomo-qq.jp/ http://www.guide.metro.tokyo.jp/
00_目次.indd
25 142 25 25 10 17 12 18 25 I 249 2,404 18 7.2 11 4.4 1 6 3 2 1 4 2 3 2 SDHI 3 7 10 93 260 3,493 26 15 2 300200 100 The Remarked Pesticides for the Efficacy Study in Japan 2013. By Naoto HAYASHI and Kyota
Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates
Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates Table 2-1. Summary of patients treated with grepafloxacin for respiratory infection 1) Out: outpatient,
Table1MIC of BAY o 9867 against standard strains
Table1MIC of BAY o 9867 against standard strains Fig.2Cumulative and Distribution Curves of MIC (S.aureus 54 strains) 106cfu/ml Fig.3Correlogram of MIC (S.aureus 54 strains) CHEMOTHERAPY 451 Fig.4Cumulative
1) Garner J. S.: The Hospital Infection Control Practices Advisory Committee, CDC, Guidelines for Isolation Precautions in Hospitals, 1996. http://wonder.cdc.gov/wonder/prevguid/ p0000419/p0000419.asp.
10-1
10 IIDA SHINKIN BANK HOTLINE 2016 IIDA SHINKIN BANK HOTLINE 2016 11 12 IIDA SHINKIN BANK HOTLINE 2016 IIDA SHINKIN BANK HOTLINE 2016 13 IIDA SHINKIN BANK HOTLINE 2016 14 IIDA SHINKIN BANK HOTLINE 2016
12-1
26 IIDA SHINKIN BANK HOTLINE 2016 IIDA SHINKIN BANK HOTLINE 2016 27 IIDA SHINKIN BANK HOTLINE 2016 28 IIDA SHINKIN BANK HOTLINE 2016 29 30 IIDA SHINKIN BANK HOTLINE 2016 IIDA SHINKIN BANK HOTLINE 2016
労 働 Health Care Quality Indicators Project - 6 data collection update report (OECD Health Working Paper No. 29) 5-Oct-7 HPV-18 ( 99 HPV 8 HPV 9 B B C
2 3-29 1 1 労 働 Health Care Quality Indicators Project - 6 data collection update report (OECD Health Working Paper No. 29) 5-Oct-7 HPV-18 ( 99 HPV 8 HPV 9 B B C 8 5 >5 1 1 / 1.1.6 Baseline reference (
WT-T600
WT-T600 LST0137-001B WM-P860 WT-UM12 WT-TR60 WT-T60 WT-M60 WT-MC60 WT-MC80 WT-MC80 WT-MC80 WT-MC80 WT-T60 WT-T60 WT-MC60 WT-M60 WT-TR60 WT-TR60 WT-T60 WT-MC60WT-T60 WT-M60 WT-M60 WT-T60 WT-T60 WT-M60 WT-MC80
まえがき
JAAS0012006 1 -------------------------------------------------------------------------------------------------------- 1 2 --------------------------------------------------------------------------------------------------------
< F2D C8E8691E63395AA8DFB2E6A7464>
1996 3,600 1997 2000 Fcurrent Fsus 2013 ABC 2012 2008 2010 2013 (Fsus) ABClimit ABCtarget 2013 ABC F ABClimit 1,070 Fsus 0.47 35% ABCtarget 900 0.8Fsus 0.38 29% ABC 1 ABC 0 F F 2010 3,402 1,302 0.50 38%
Table 1. Number and stundard length of smallmouth bass examined in the study
Taiga Yodo* and Kei'ichiro Iguchi. 2003. Feeding habits of introduced smallmouth bass in Lakes Aoki and Nojiri, Japan. Japan. J. Ichthyol., 50(1): 47-54. Abstract To elucidate the feeding habits of smallmouth
untitled
, No. 172, 2006 062-09222-2-1996 2002 - -1- 1996 Oncorhynchus mykiss Salmo trutta 19991996 7218 1970 1999 2002aTaniguchi et al. 2002 1993 2001Morita et al. 2004Hasegawa et al. 2004 1993 1999Taniguchi et
スライド 1
不活化ポリオワクチンの円滑な導入に関する検討会 第 2 回会議 諸外国の OPV から IPV への 移行時の対応等 2011 年 10 月 14 日 ( 金 ) 中野貴司 ( 川崎医科大学小児科 ) 米国における OPV IPV の移行 1.1997 年 1 月より IPV/OPV sequential( 併用 ) スケジュール IPV を 2 ヵ月,4 ヵ月の 2 回 OPV を 6-18 ヵ月,4-6
CHEMOTHERAPY APRIL 1992 VOL. 40 S- 1 Table 1-1. Comparative in vitro activity of meropenem against clinical isolates CNS: coagulase-negative staphylococci CHEMOTHERAPY APRIL 1992 Table 1-2. Comparative
40B: 43-54 2010 43 2010 1 27 Satoshi Shimai 1 and Shigehiro Fujimoto 2 1 Center for Liberal Arts and Education, Minami-Kyushu University, Miyakonojo,
40B: 43-54 2010 2010 1 27 Satoshi Shimai 1 and Shigehiro Fujimoto 2 1 Center for Liberal Arts and Education, Minami-Kyushu University, Miyakonojo, Miyazaki 885-0035, Japan; 2 Miyakonojo Public Health Institute,
Fig.1 MICs of penicillins against 24 strains of B. pertussis Fig.2 MICs of cepherns against 24 strains of B. pertussis Fig.3 MICs of macrolides against 24 strains of B. pertussis Fig.4 MICs of nalidixic
... 4... 5 (FA )... 6... 6 A FA... 7... 7. FA... 8.... 9.... 10. FA... 11 B. FA... 12 C 3 ()... 13 FA... 13 FA... 14... 14 FA... 14 ()... 15... 16...
... 4... 5 (FA )... 6... 6 A FA... 7... 7. FA... 8.... 9.... 10. FA... 11 B. FA... 12 C 3 ()... 13 FA... 13 FA... 14... 14 FA... 14 ()... 15... 16... 17 ()... 20... 20... 21... 22 D... 23 E ()... 23...
g 51 52
10 12 A 12 C 12 13 13 13 13 16 16 18 18 18 23 23 23 23 23 A 24 25 25 26 28 28 30 32 38 38 41 42 43 10 43 11 45 48 48 120g 51 52 12 3 12 3 350g 120g 1 7 10 260g 90g 90g 30g 9 11 2 gg1 g 1 120g 10 1 12 6
.D.q
March a b b b b b b a a a a aaaa March b a b a a March b b b b a a a March a c a aaaa b b b a c c b b b b b March b a a a a b b a a b b a a a March a a b b b b March b a b b b b b March a b a b a b a b
:,, : - 7 -
31 ~ ~ - 6 - :,, : - 7 - (),,,,,,; ~ ~ *1 *2 6,,,~,,~ - 8-32 ,, ( );( ),,,,,, ~ ~ ~,,,, (),,,,, - 9 - 33 ~*~ ~~ ~, ~ ~ ~ ~ ~, ~~,,,, - 10 - BCG () g ) BCG BCG,, 34 ,,,, (),,,,,,,,,,,,,, () ( 3 90 [7 6
論文
*, 1 1 Selection of superior Frankia spp. for rapid cultivation of Alnus hirsuta seedlings Maki Saito *, 1 and Mikio Hasegawa 1 4 2 4 28 9 30 cm 30 cm 70 % 5 Abstract: In order to develop the rapid cultivation
38
979 25 98 594 324 333 348 347 35 23 78 44 758 37 38 24 8 2 7 44 32 8 2 2 24 7 4 3 2 9 8 7 3 6 4 3 7 4 8 2 5 2 6 3 24 8 3 74 46 344 9 6 2 3 2 24 7 4 3 2 2 9 9 7 3 2 4 3 758 223 39 () 96.5g (2),33.6g 24.572g,33.6g
一休デイサービスセンター
2770105472 2770105472 2776300135 2776300135 - - 072-274-7219 072-204-7319 http://www.19day.jp/ 072-274-7219 072-204-7319 http://www.19day.jp/ 2007 11 1 45 2007 11 1 45 11 12 4km 10 11 -2- 3-3 - 4 - 5 11
MAWGD08Y 5 5 5 5 5 5 6 5 5 6 6 7 5 6 7L 55L 5L 0L 8L 0.0 6.0.0.0 0.5 8 7 0 0 96ml 7ml 60ml 0ml ml 8ml 7ml 0ml 0ml ml 96 7 60 0 6ml ml 0ml 7ml ml 8ml 7ml 0ml 0ml ml 8 7 0 0 5 6 7 5 6 5 (0)890-750
植物防疫 第６４巻 ３号
21 185 21 21 10 22 21 I 275 1,894 24 8.7 14 5.1 1 416 100 50 The Remarked Pesticides for the Efficacy Study in Japan2009. By Naoto HAYASHI and Kyota NUMATA JPPA 21 21 14 2/3 WDG 27 196 18 166 294 3,529
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
23 3 11 24 21 24 25 4 28 4 2 7 161 2,692 28 12 14 18 18 380 5 3 1 27 21 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213 640 416 82,979
CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates
VOL.39 S-1 CHEMOTHERAPY FEB. 1981 Table 1. Activity of cefpirome and others against clinical isolates VOL.39 S-1 CHEMOTHERAPY FEB. 1991 72 M, 55.5 kg 66 F, 53 kg Chronic bronchitis Bronchopneumonia Peak
CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus
VOL. 32 S-4 CHEMOTHERAPY Fig. 1 Chemical structure of sodium cefoperazone Fig. 2 Chemical structure of sodium cefoperazone CHEMOTHERAPY JUN. 1984 Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter
d-00
283-0105 298 TEL. 0475-76-0839 FAX. 0475-76-0838 400g 300 4950399167708 14 220g 300 4950399066780 Page 1 300g 200 4950399066766 100 400g 300 4950399167722 350g 160 4950399066735 100 600g 350 4950399167685
